Trial Search Results
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Stanford is currently not accepting patients for this trial.
Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical
resection of their tumors
Exclusion Criteria:- Patients without non-small cell lung cancer
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study